EBD Group’s partneringONE® to facilitate partnering at the first edition of BIOLATAM in Bogota, Colombia
EBD Group, organizer of the life science industry’s leading partnering events, and the Spanish Bioindustry Association (ASEBIO) with Invest in Bogota, announce their collaboration atBIOLATAM 2013 in Bogota, Colombia. EBD Group will provide partneringONE®, the conference partnering solution for the life sciences and the industry’s most advanced collaboration software.
BIOLATAM is a partnering forum with global reach and Latin American focus, open to companies, researchers and venture capital companies. BIOLATAM will be held December 9–10, 2013, and will welcome global attendees from the enterprise, academic, research and investor sectors, as well as from institutions related to biotechnology and with specific interests in Latin America. The conference program will cover bio-economy and bio-fuels, advanced therapies, food bio-technology, personalized medicine, sanitation products and venture capital, among other topics.
“I am pleased we will be working with ASEBIO and Invest in Bogota to provide partneringONE at BIOLATAM,” said Carola Schropp, President of EBD Group. “There is great potential in the Latin America biotechnology sector, and partneringONE is uniquely positioned to facilitate highly productive partnering that will result in new collaborative opportunities to benefit economic growth.”
BIOLATAM is being co-organized by the Spanish Bioindustry Association (ASEBIO), the organizer of BioSpain, the fifth largest trade show in the biotech sector worldwide in terms of business development meetings in 2012, along with Invest in Bogota, the agency for the promotion of the Colombian capital city. EBD Group provided partneringONE to BioSpain 2012.
“EBD Group is well known in the industry for the high caliber of their events, and we were aware of the excellence of their partneringONE solution from our experience working with them on BioSpain,” said Regina Revilla, President of ASEBIO. “When we originally conceived of BIOLATAM, we knew the importance of having a seamless partnering component, and it just made sense to work with EBD Group.”
partneringONE facilitates one-to-one meetings to take place at the event between companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups. Meetings are scheduled prior to the event and delegates can manage their schedules online. Up to 20 life science events each year rely on the robust platform of partneringONE, provided as a third-party service.
The system generates over 40,000 one-to-one meetings annually at EBD Group’s six life science partnering events held around the world. With partneringONE, pharma and biotech dealmakers can create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators. For more about partneringONE, go towww.partneringone.com/app/log_on_select.php
For more information about BIOLATAM 2013 go to www.biolatam.org/en/index.html
The Spanish Association of Bio-Companies (ASEBIO) is comprised by 235 partners, most of them small companies created from research conducted at universities and national research centers.
Since 1999 ASEBIO has been a meeting and promotion platform for organizations interested in the development of the national bio-technology scenario. To this end, it collaborates closely with the regional, national and European administrations, as well as with all other social organizations interested in using bio-technology to improve people’s quality of life, the environment and to promote the generation of skilled labor.
About Invest in Bogota
Invest in Bogota is the agency for the promotion of investments into the Bogota Region, a public-private initiative between the Bogota Chamber of Commerce and the City. Its mission is to support investors exploring opportunities in Bogota. In 2009 it was rated by the World Bank as the best investment promotion agency in a developing country. It provides investors with specialized services throughout their investment process: exploration, establishment, operation and reinvestment, free of charge and with full confidentiality.
Communication Manager ASEBIO
Tfno. + 34 91 2109374/10
Fax. +34 91 2500063
Movile: 663 117 293
Marketing and Communications Officer Invest in Bogota
Tfno. +57 1 7423030
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.